Realtime | Geld | Brief | Zeit |
---|---|---|---|
2,660 | 2,710 | 07:00 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | |
---|---|---|---|---|
Fr | GeoVax Labs, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | |
Do | GeoVax Labs, Inc. - 8-K, Current Report | 1 | SEC Filings | |
02.05. | GeoVax reports Q1 results | 4 | Seeking Alpha | |
02.05. | Geovax highlights progress on mpox vaccine and COVID-19 trial advancements | 1 | Seeking Alpha | |
01.05. | GeoVax Labs, Inc. - 8-K, Current Report | - | SEC Filings | |
01.05. | GeoVax Labs, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | |
28.04. | Geovax Labs is a buy, Roth says | 7 | Cantech Letter | |
GEOVAX LABS Aktie jetzt für 0€ handeln | ||||
14.04. | GeoVax ordered to halt work on COVID-19 vaccine project by ATI | 3 | Investing.com | |
14.04. | GeoVax muss Arbeit an COVID-19-Impfstoffprojekt auf Anweisung von ATI einstellen | 8 | Investing.com Deutsch | |
14.04. | GeoVax Labs, Inc. - 8-K, Current Report | 1 | SEC Filings | |
27.03. | GeoVax Labs, Inc. - 10-K, Annual Report | 2 | SEC Filings | |
26.03. | What's Next: Geovax Labs' Earnings Preview | 2 | Benzinga.com | |
25.03. | GeoVax Labs, Inc. - 8-K, Current Report | 2 | SEC Filings | |
22.01. | GeoVax Labs, Inc. - 8-K, Current Report | 1 | SEC Filings | |
18.12.24 | GeoVax Labs, Inc. - 8-K, Current Report | 2 | SEC Filings | |
18.12.24 | Nitches, inc: Nitches Inc. Updates Shareholders on Amazon Integration, GovX Integration, and 2025 Growth Strategy for InTheZone Labs | 276 | ACCESS Newswire | |
09.12.24 | GeoVax, Inc.: GeoVax Receives Notice of Allowance For Cancer Vaccine Patent | 287 | GlobeNewswire (Europe) | |
20.08.24 | GeoVax, Inc.: GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market | 429 | GlobeNewswire (Europe) | |
31.07.24 | GeoVax, Inc.: Update: GeoVax Announces Phase 2 Plans for Gedeptin Cancer Therapy Following Clinical Advisory Committee Review | 253 | GlobeNewswire (Europe) | |
31.07.24 | GeoVax, Inc.: GeoVax Announces Phase 2 Plans for Gedeptin Cancer Therapy Following Clinical Advisory Committee Review | 220 | GlobeNewswire (Europe) |